Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
33.41
+0.47 (1.43%)
At close: Mar 9, 2026, 4:00 PM EDT
32.76
-0.65 (-1.95%)
After-hours: Mar 9, 2026, 6:09 PM EDT
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.69 billion as of March 9, 2026. Its market cap has increased by 13.33% in one year.
Market Cap
1.69B
Enterprise Value
1.24B
1-Year Change
13.33%
Ranking
Category
Stock Price
$33.41
Market Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.69B, a decrease of -5.69%. That is a compound annual growth rate of -1.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 1.67B | -4.79% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galecto | 1.74B |
| Vericel | 1.71B |
| Trevi Therapeutics | 1.71B |
| Olema Pharmaceuticals | 1.70B |
| Pharvaris | 1.68B |
| Harmony Biosciences Holdings | 1.64B |
| Innoviva | 1.63B |
| Novavax | 1.63B |